Cibus, Inc. (CBUS)
Materials · Nasdaq
Agricultural biotechnology company using proprietary gene editing (RTDS) to develop plant traits for major crops, with primary focus on herbicide-tolerant rice.
What Cibus, Inc. does
Cibus is an agricultural biotechnology company that develops plant traits—specific genetic characteristics in plant seeds—using its proprietary Rapid Trait Development System (RTDS) gene editing platform. The company licenses these edited traits to seed companies for royalties. Its primary near-term focus is herbicide-tolerant rice traits with estimated addressable royalties exceeding $200 million, while it also develops sustainable ingredients including lauric oils and bio fragrance products through fermentation technology.
Themes: ["Gene editing / agricultural biotechnology","Crop productivity and yield","Herbicide tolerance traits","Sustainable agriculture","Climate adaptation (drought/heat tolerance)","Bio-based ingredients and fragrances","Seed trait licensing and royalties"]
Fundamentals
- Price$2.02 as of 2026-07-10 close
- Market cap$154M as of 2026-07-13
- 1-year return+27.0% as of 2026-07-10 close
- Net margin-2366.3% as of 2026-07-13
- Gross margin+100.0% as of 2026-07-13
- ROE-225.6% as of 2026-07-13
- Debt / equity6.89 as of 2026-07-13
- Revenue growth (YoY)-9.8% as of 2026-07-13
- Revenue CAGR (3y)+185.1% SEC XBRL
- Beta1.74 as of 2026-07-13
Key risks (from latest filing)
[]
Competitors & peers
- Corteva Agriscience
- BASF (agricultural division)
- Syngenta
- Bayer Crop Science
- Calyxt
- Ginkgo Bioworks (fermentation/synthetic biology)
Fundamentals: Finnhub, as of 2026-07-13. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-10.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.